YELLOW-III: statin plus evolocumab thickened fibrous caps over 30% in 6 months
Louis details YELLOW-III: in 6 months, high-dose statin plus a PCSK9 inhibitor with LDL of 30-40 mg/dL strengthened the fibrous cap and reduced total plaque volume, mainly by shrinking the soft lipid core, in a 'melting butter' pattern.
